These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35907197)

  • 1. Impact of radiotherapy delay following biopsy for patients with unresected glioblastoma.
    Gao S; Jin L; Moliterno J; Corbin ZA; Bindra RS; Contessa JN; Yu JB; Park HS
    J Neurosurg; 2023 Mar; 138(3):610-620. PubMed ID: 35907197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short delay in initiation of radiotherapy for patients with glioblastoma-effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group database.
    Blumenthal DT; Won M; Mehta MP; Gilbert MR; Brown PD; Bokstein F; Brachman DG; Werner-Wasik M; Hunter GK; Valeinis E; Hopkins K; Souhami L; Howard SP; Lieberman FS; Shrieve DC; Wendland MM; Robinson CG; Zhang P; Corn BW
    Neuro Oncol; 2018 Jun; 20(7):966-974. PubMed ID: 29462493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
    Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
    J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary glioblastoma multiforme in younger patients: a single-institution experience.
    Ulutin C; Fayda M; Aksu G; Cetinayak O; Kuzhan O; Ors F; Beyzadeoglu M
    Tumori; 2006; 92(5):407-11. PubMed ID: 17168433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma.
    Sun MZ; Oh T; Ivan ME; Clark AJ; Safaee M; Sayegh ET; Kaur G; Parsa AT; Bloch O
    J Neurosurg; 2015 May; 122(5):1144-50. PubMed ID: 25768833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Factors and Treatment Patterns in the Management of Giant Cell Glioblastoma.
    Jin MC; Wu A; Xiang M; Azad TD; Soltys SG; Li G; Pollom EL
    World Neurosurg; 2019 Aug; 128():e217-e224. PubMed ID: 31009783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delay in starting radiotherapy due to neoadjuvant therapy does not worsen survival in unresected glioblastoma patients.
    Balaña C; Estival A; Teruel I; Hardy-Werbin M; Sepulveda J; Pineda E; Martinez-García M; Gallego O; Luque R; Gil-Gil M; Mesia C; Del Barco S; Herrero A; Berrocal A; Perez-Segura P; De Las Penas R; Marruecos J; Fuentes R; Reynes G; Velarde JM; Cardona A; Verger E; Panciroli C; Villà S
    Clin Transl Oncol; 2018 Dec; 20(12):1529-1537. PubMed ID: 29737461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal timing of chemoradiotherapy after surgical resection of glioblastoma: Stratification by validated prognostic classification.
    Press RH; Shafer SL; Jiang R; Buchwald ZS; Abugideiri M; Tian S; Morgan TM; Behera M; Sengupta S; Voloschin AD; Olson JJ; Hasan S; Blumenthal DT; Curran WJ; Eaton BR; Shu HG; Zhong J
    Cancer; 2020 Jul; 126(14):3255-3264. PubMed ID: 32342992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of radiotherapy for elderly patients with glioblastoma.
    Scott J; Tsai YY; Chinnaiyan P; Yu HH
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):206-10. PubMed ID: 20675068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal Timing of Radiotherapy Following Gross Total or Subtotal Resection of Glioblastoma: A Real-World Assessment using the National Cancer Database.
    Buszek SM; Al Feghali KA; Elhalawani H; Chevli N; Allen PK; Chung C
    Sci Rep; 2020 Mar; 10(1):4926. PubMed ID: 32188907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reoperation for Recurrent Glioblastoma and Its Association With Survival Benefit.
    Tully PA; Gogos AJ; Love C; Liew D; Drummond KJ; Morokoff AP
    Neurosurgery; 2016 Nov; 79(5):678-689. PubMed ID: 27409404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis.
    Hanna C; Lawrie TA; Rogozińska E; Kernohan A; Jefferies S; Bulbeck H; Ali UM; Robinson T; Grant R
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013261. PubMed ID: 32202316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent chemoradiotherapy versus radiotherapy alone for "biopsy-only" glioblastoma multiforme.
    Kole AJ; Park HS; Yeboa DN; Rutter CE; Corso CD; Aneja S; Lester-Coll NH; Mancini BR; Knisely JP; Yu JB
    Cancer; 2016 Aug; 122(15):2364-70. PubMed ID: 27172136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newly diagnosed glioblastoma: adverse socioeconomic factors correlate with delay in radiotherapy initiation and worse overall survival.
    Pollom EL; Fujimoto DK; Han SS; Harris JP; Tharin SA; Soltys SG
    J Radiat Res; 2018 Mar; 59(suppl_1):i11-i18. PubMed ID: 29432548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Timing of Adjuvant Chemoradiation for Glioblastoma in a Large Hospital Database.
    Osborn VW; Lee A; Garay E; Safdieh J; Schreiber D
    Neurosurgery; 2018 Nov; 83(5):915-921. PubMed ID: 29092047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative radiotherapy of glioblastoma multiforme: analysis and critical assessment of different treatment strategies and predictive factors.
    Piroth MD; Gagel B; Pinkawa M; Stanzel S; Asadpour B; Eble MJ
    Strahlenther Onkol; 2007 Dec; 183(12):695-702. PubMed ID: 18040615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The timing of cranial radiation in elderly patients with newly diagnosed glioblastoma multiforme.
    Lai R; Hershman DL; Doan T; Neugut AI
    Neuro Oncol; 2010 Feb; 12(2):190-8. PubMed ID: 20150386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of timeliness of adjuvant chemotherapy and radiotherapy on the outcomes of breast cancer; a pooled analysis of three clinical trials.
    Abdel-Rahman O
    Breast; 2018 Apr; 38():175-180. PubMed ID: 29432980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Craniotomy for recurrent glioblastoma: Is it justified? A comparative cohort study with outcomes over 10 years.
    Mukherjee S; Wood J; Liaquat I; Stapleton SR; Martin AJ
    Clin Neurol Neurosurg; 2020 Jan; 188():105568. PubMed ID: 31739155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing of Adjuvant Radiotherapy in Glioblastoma Patients: A Single-Institution Experience With More Than 400 Patients.
    Wang TJ; Jani A; Estrada JP; Ung TH; Chow DS; Soun JE; Saad S; Qureshi YH; Gartrell R; Isaacson SR; Cheng SK; McKhann GM; Bruce JN; Lassman AB; Sisti MB
    Neurosurgery; 2016 May; 78(5):676-82. PubMed ID: 26440447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.